Woolery-Lloyd Heather, Valins Whitney
University of Miami, Department of Dermatology and Cutaneous Surgery, Miami Beach, Florida.
J Clin Aesthet Dermatol. 2009 Jun;2(6):28-31.
Hyperhidrosis is a common dermatological condition that has a tremendous impact on the quality of life of affected patients. Aluminum chloride hexahydrate is considered first-line therapy for patients with mild-to-moderate hyperhidrosis. This treatment has been proven to be effective in the treatment of hyperhidrosis; however, its use has been limited by significant irritation. In many patients, the irritant dermatitis is so severe that, despite clinical efficacy, this therapy must be discontinued. There are many topical aluminum chloride therapies available. Observations from a busy hyperhidrosis practice revealed decreased irritation and increased efficacy with a novel therapy that combines 15% aluminum chloride hexahydrate with 2% salicylic acid in a gel base. This combination of 15% aluminum chloride hexahydrate with 2% salicylic acid offers patients who have failed aluminum chloride hexahydrate in the past excellent efficacy with minimal irritation. We report seven cases of patients with a history of severe irritation from aluminum chloride who maintained excellent results with this new topical without any significant irritation.
多汗症是一种常见的皮肤病,对受影响患者的生活质量有巨大影响。六水合氯化铝被认为是轻至中度多汗症患者的一线治疗方法。这种治疗方法已被证明对多汗症有效;然而,其使用受到严重刺激的限制。在许多患者中,刺激性皮炎非常严重,以至于尽管有临床疗效,这种治疗方法也必须停止。有许多外用氯化铝疗法可供选择。在一个繁忙的多汗症诊所的观察发现,一种将15%六水合氯化铝与2%水杨酸混合在凝胶基质中的新型疗法可减少刺激并提高疗效。这种15%六水合氯化铝与2%水杨酸的组合为过去使用六水合氯化铝失败的患者提供了极佳的疗效,且刺激最小。我们报告了7例有氯化铝严重刺激史的患者,他们使用这种新的外用药物后效果极佳,且没有任何明显刺激。